Critics say that, if RFK Jr. is made secretary of the HHS, a radical antiestablishment medical movement with roots in past ...

Findings from the HELEN-006 trial suggest a potential shift in neoadjuvant treatment practices for patients with HER2-positive early breast cancer, specifically using nab-paclitaxel to reduce ...

President-elect Donald Trump has tapped Dr Jay Bhattacharya, a Stanford health economist, to lead the National Institutes of Health.

In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients ...

Imkeldi is supplied as a strawberry-flavored oral solution in a 140 mL, child-resistant, tamper-evident bottle.

A CXB boost continues to provide an organ preservation benefit at 5 years, though there is some local regrowth after 3 years, ...

To run the US Centers for Disease Control and Prevention, Trump has turned to David Weldon, MD, a long-time internist who interrupted his medical career to represent a Florida district for 7 terms in ...

NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.

Clinical factors associated with an increased risk of psychological distress included younger age, female sex, advanced pathological/tumor stage, and preoperative setting.

"In a country with the wealth and resources of the USA, it is intolerable that so many are living in conditions and with health outcomes akin to those of an entirely different country," the ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Adding pembrolizumab to radiotherapy and surgery can improve disease-free survival in patients with certain types of sarcoma.